# FDA Inspection 1230049 - Novitium Pharma LLC - February 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/c4edb0db-e08e-4305-9915-71b848ff4d32
Source feed: FDA_Inspections

> FDA inspection 1230049 of Novitium Pharma LLC, February 16, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230049
- Company Name: Novitium Pharma LLC
- Inspection Date: 2024-02-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1231393 - 2024-02-01
- [FDA Inspection 1204308 - 2023-03-31](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/071be200-4a09-4449-947c-fe0d400d5cc8)
- FDA Inspection 1145707 - 2021-07-08
- [FDA Inspection 1080904 - 2019-02-04](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/39280e41-44ce-4cff-83ec-fff6aa1e07c5)
- FDA Inspection 1053573 - 2018-05-09

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gabrielle-j-swain/55f33430-41dc-4fae-bac0-ec6ea340feb6)

Company: https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c